» Articles » PMID: 36447237

Predictive Model for Long COVID in Children 3 Months After a SARS-CoV-2 PCR Test

Abstract

Background: To update and internally validate a model to predict children and young people (CYP) most likely to experience long COVID (i.e. at least one impairing symptom) 3 months after SARS-CoV-2 PCR testing and to determine whether the impact of predictors differed by SARS-CoV-2 status.

Methods: Data from a nationally matched cohort of SARS-CoV-2 test-positive and test-negative CYP aged 11-17 years was used. The main outcome measure, long COVID, was defined as one or more impairing symptoms 3 months after PCR testing. Potential pre-specified predictors included SARS-CoV-2 status, sex, age, ethnicity, deprivation, quality of life/functioning (five EQ-5D-Y items), physical and mental health and loneliness (prior to testing) and number of symptoms at testing. The model was developed using logistic regression; performance was assessed using calibration and discrimination measures; internal validation was performed via bootstrapping and the final model was adjusted for overfitting.

Results: A total of 7139 (3246 test-positives, 3893 test-negatives) completing a questionnaire 3 months post-test were included. 25.2% (817/3246) of SARS-CoV-2 PCR-positives and 18.5% (719/3893) of SARS-CoV-2 PCR-negatives had one or more impairing symptoms 3 months post-test. The final model contained SARS-CoV-2 status, number of symptoms at testing, sex, age, ethnicity, physical and mental health, loneliness and four EQ-5D-Y items before testing. Internal validation showed minimal overfitting with excellent calibration and discrimination measures (optimism-adjusted calibration slope: 0.96575; C-statistic: 0.83130).

Conclusions: We updated a risk prediction equation to identify those most at risk of long COVID 3 months after a SARS-CoV-2 PCR test which could serve as a useful triage and management tool for CYP during the ongoing pandemic. External validation is required before large-scale implementation.

Citing Articles

How do children understand and respond to the EQ-5D-Y-3L? A mixed methods study in a community-based sample of 6-12-year-olds.

Khanna D, Lay K, Khadka J, Mpundu-Kaambwa C, Ratcliffe J Health Qual Life Outcomes. 2024; 22(1):105.

PMID: 39633400 PMC: 11619400. DOI: 10.1186/s12955-024-02320-4.


Predicting post-COVID-19 condition in children and young people up to 24 months after a positive SARS-CoV-2 PCR-test: the CLoCk study.

Nugawela M, Stephenson T, Shafran R, Chalder T, Dalrymple E, Ford T BMC Med. 2024; 22(1):520.

PMID: 39511637 PMC: 11545583. DOI: 10.1186/s12916-024-03708-1.


Clinical Features and Vaccination Effects among Children with Post-Acute Sequelae of COVID-19 in Taiwan.

Hsu Y, Chen P, Tsai Y, Wei C, Wu L, Hsieh K Vaccines (Basel). 2024; 12(8).

PMID: 39204035 PMC: 11359259. DOI: 10.3390/vaccines12080910.


Long COVID in Children and Adolescents: A Critical Review.

Rothensteiner M, Leeb F, Gotzinger F, Tebruegge M, Zacharasiewicz A Children (Basel). 2024; 11(8).

PMID: 39201907 PMC: 11352730. DOI: 10.3390/children11080972.


Post-Covid-19 condition (Long Covid) in children and young people 12 months after infection or reinfection with the Omicron variant: a prospective observational study.

Pinto Pereira S, Nugawela M, Stephenson T, Foret-Bruno P, Dalrymple E, Xu L Sci Rep. 2024; 14(1):9957.

PMID: 38693285 PMC: 11063180. DOI: 10.1038/s41598-024-60372-4.


References
1.
Stephenson T, Shafran R, Ladhani S . Long COVID in children and adolescents. Curr Opin Infect Dis. 2022; 35(5):461-467. PMC: 9553244. DOI: 10.1097/QCO.0000000000000854. View

2.
Borch L, Holm M, Knudsen M, Ellermann-Eriksen S, Hagstroem S . Long COVID symptoms and duration in SARS-CoV-2 positive children - a nationwide cohort study. Eur J Pediatr. 2022; 181(4):1597-1607. PMC: 8742700. DOI: 10.1007/s00431-021-04345-z. View

3.
Hippisley-Cox J, Coupland C, Brindle P . Development and validation of QRISK3 risk prediction algorithms to estimate future risk of cardiovascular disease: prospective cohort study. BMJ. 2017; 357:j2099. PMC: 5441081. DOI: 10.1136/bmj.j2099. View

4.
Stephenson T, Allin B, Nugawela M, Rojas N, Dalrymple E, Pereira S . Long COVID (post-COVID-19 condition) in children: a modified Delphi process. Arch Dis Child. 2022; 107(7):674-680. PMC: 8983414. DOI: 10.1136/archdischild-2021-323624. View

5.
Righi E, Mirandola M, Mazzaferri F, Dossi G, Razzaboni E, Zaffagnini A . Determinants of persistence of symptoms and impact on physical and mental wellbeing in Long COVID: A prospective cohort study. J Infect. 2022; 84(4):566-572. PMC: 8828388. DOI: 10.1016/j.jinf.2022.02.003. View